Biotage

Biotage
About Us
Change country

Follow us:
Share:
Subscribe:

About Us

About BiotageBiotage is a Global Impact Tech Company committed to solving society’s problems. We offer workflow solutions and products to customers in drug discovery and development, analytical testing and water and environmental testing. Biotage is contributing to sustainable science with the goal to make the world healthier, greener and cleaner – HumanKind Unlimited. Our customers span a broad range of market segments including pharmaceutical, biotech, contract research and contract manufacturers as well as clinical, forensic and academic laboratories in addition to organizations focused on food safety, clean water and environmental sustainability. Biotage is headquartered in Uppsala in Sweden and employs 497 people worldwide. The Group had sales of 1,232 MSEK in 2021 and our products are sold in more than 80 countries. Biotage’s share (BIOT) is listed in the Large Cap segment on the NASDAQ Stockholm.Website: www.biotage.com

Pick a time period -

Tags ( Active)

All Regulatory Non-Regulatory

Biotage’s shares now traded on the Mid Cap segment of Nasdaq OMX Nordic

Mon, Jan 02, 2017 09:46 CET

As from today, Biotage AB (BIOT.ST) change segment at Nasdaq OMX Nordic, from the Small Cap Segment to the Mid Cap Segment. Contact persons:Torben Jörgensen, CEOTel: +46 707 490584, torben.jorgensen@biotage.comErika Söderberg-Johnson, CFOTel: +46 707 204820, erika.soderberg.johnson@biotage.com About BiotageBiotage offers efficient separation technologies from analysis to industrial scale and high quality solutions for analytical chemistry from research to commercial analysis laboratories. Biotage’s products are used by government authorities, academic institutions,

There are no items matching the current filter

There are no more items matching the current filter

Share

About Us

Biotage’s shares now traded on the Mid Cap segment of Nasdaq OMX Nordic